If you use batteries with a balcony power plant, you can control them according to your needs. Can Fritz SmartEnergy 250 ...

The efficacy of teclistamab, a bispecific antibody targeting B-cell maturation antigen and CD3, as early-line monotherapy in relapsed or refractory multiple myeloma is unclear. We randomly assigned ...

AUSTIN, Texas — Editor's note: Austin police released more details about the suspects, as well as a timeline of events in the latest update. Three suspects have been taken into custody following ...

The 2026 Cubs made history less than two months into the regular season by putting together two win streaks of at least 10 games for the first time in 91 years, doing so in a span of 23 games. With ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Here are some Python interview questions with their answers, ranging from basic to advanced. 9. Question: What are decorators in Python and how are they used? Answer: Decorators provide a way to ...

This week saw multiple attacks in the U.S. that the FBI is investigating as terrorism. Experts say they reflect an accelerating threat environment fed by foreign conflict and online radicalization. In ...

Minimal residual disease (MRD) has emerged as a key prognostic factor in multiple myeloma (MM), allowing a more accurate evaluation of treatment efficacy beyond conventional complete remission.

Just over half (51%) of American households include a dog and more than a third (37%) have a cat, according to the American Pet Products Association. Pet insurance can help you be better prepared for ...

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental. JITing, or “just-in-time” compilation, can make relatively slow ...

In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...